Drug · CHEMBL596
Comparisons in its trials167
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
1 to 20 of 167
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Propofol vs Fentanyl Plus Midazolam Only: deaths from any cause | 0 of 300 | 0 of 300 | 600 | NCT02937506 | Trial comparisons |
| Propofol vs Fentanyl Plus Midazolam Only: serious adverse events | 0 of 300 | 0 of 300 | 600 | NCT02937506 | Trial comparisons |
| Fentanyl Buccal Tablets (FBT) vs Immediate-Release Oxycodone: serious adverse events | 1 of 281 | 0 of 284 | 565 | NCT00463047 | Trial comparisons |
| Fentanyl Sublingual Spray Titration vs Fentanyl Sublingual Spray Maintenance: serious adverse events | 33 of 229 | 178 of 269 | 498 | NCT00538863 | Trial comparisons |
| Epidural Fentanyl vs Epidural Bupivacaine Plus Fentanyl (Bupivacaine): Number of Participants Whose Newborns Received an APGAR Score of <=3 at 5 Min | 2 of 156 | 1 of 154 | 310 | NCT01621230 | Trial comparisons |
| Bupivacaine Plus Fentanyl vs Fentanyl Alone: deaths from any cause | 0 of 154 | 0 of 156 | 310 | NCT01621230 | Trial comparisons |
| Epidural Fentanyl vs Epidural Bupivacaine Plus Fentanyl (Bupivacaine): Number of Participants Whose Newborns Received an APGAR Score of <=3 at 1 Min | 14 of 156 | 11 of 154 | 310 | NCT01621230 | Trial comparisons |
| Bupivacaine Plus Fentanyl vs Fentanyl Alone: serious adverse events | 0 of 154 | 0 of 156 | 310 | NCT01621230 | Trial comparisons |
| Ultrasonography vs Palpation: Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Needle Pass | 40 of 140 | 45 of 140 | 280 | NCT03792191 | Trial comparisons |
| Ultrasonography vs Palpation: Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Skin Puncture | 108 of 140 | 111 of 140 | 280 | NCT03792191 | Trial comparisons |
| Ultrasonography vs Palpation: Number of Participants With Vascular Puncture | 9 of 140 | 9 of 140 | 280 | NCT03792191 | Trial comparisons |
| Ultrasonography vs Palpation: Number of Participants With Failure to Obtain Free Cerebrospinal Fluid Flow | 0 of 140 | 0 of 140 | 280 | NCT03792191 | Trial comparisons |
| Ultrasonography vs Palpation: Number of Participants With Paresthesia | 16 of 140 | 17 of 140 | 280 | NCT03792191 | Trial comparisons |
| Ultrasonography vs Palpation: Number of Participants With Failed Spinal Block | 3 of 140 | 4 of 140 | 280 | NCT03792191 | Trial comparisons |
| Ultrasonography vs Palpation: deaths from any cause | 0 of 140 | 0 of 140 | 280 | NCT03792191 | Trial comparisons |
| Ultrasonography vs Palpation: serious adverse events | 0 of 140 | 0 of 140 | 280 | NCT03792191 | Trial comparisons |
| Individualized Opioid Analgesia vs Conventional Opioid Analgesia: The Percentage of Patients Requiring at Least One Medical Intervention for Respiratory Events | 16 of 134 | 29 of 130 | 264 | NCT02990910 | Trial comparisons |
| Individualized Opioid Analgesia vs Conventional Opioid Analgesia: deaths from any cause | 16 of 134 | 29 of 130 | 264 | NCT02990910 | Trial comparisons |
| Individualized Opioid Analgesia vs Conventional Opioid Analgesia: serious adverse events | 0 of 134 | 0 of 130 | 264 | NCT02990910 | Trial comparisons |
| Propofol Intervention vs Midazolam/Fentanyl Intervention: deaths from any cause | 0 of 126 | 0 of 136 | 262 | NCT01488045 | Trial comparisons |
pipelines-2026-09-18-0.3.1
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL596/comparisons